Načítá se...
Late Dual Endothelin Receptor Blockade with Bosentan Restores Impaired Cerebrovascular Function in Diabetes
AIMS: Up-regulation of the endothelin (ET) system in type-2 diabetes increases contraction and decreases relaxation in basilar artery. We showed that 1) ET-receptor antagonism prevents diabetes-mediated cerebrovascular dysfunction; and 2) glycemic control prevents activation of the ET-system in diab...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4096617/ https://ncbi.nlm.nih.gov/pubmed/24434796 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lfs.2013.12.231 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|